Evidence map›Paper›PMID 35625250›Full record

ReviewAntibiotics (Basel, Switzerland)2022

Recent Developments in Methicillin-Resistant

Palanichamy Nandhini, Pradeep Kumar, Suresh Mickymaray, Abdulaziz S Alothaim, Jayaprakash Somasundaram, Mariappan Rajan

Open access · goldAbstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed
23.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 259 citations in OpenAlex.

  1. IntegratedACS omega · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Microbiology spectrum · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Methicillin-ResistantMicroorganisms · 2026
    Review
  18. Article
  19. Methicillin-resistantiScience · 2026
    Review
  20. Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Palanichamy NandhiniBiomaterials in Medicinal Chemistry Laboratory, Department of Natural Products Chemistry, School of Chemistry, Madurai Kamaraj University, Madurai 625021, India.
Pradeep KumarDepartment of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa.ORCID 0000-0002-8640-4350
Suresh MickymarayDepartment of Biology, College of Science, Al-Zulfi, Majmaah University, Majmaah 11952, Saudi Arabia.
Abdulaziz S AlothaimDepartment of Biology, College of Science, Al-Zulfi, Majmaah University, Majmaah 11952, Saudi Arabia.
Jayaprakash SomasundaramDepartment of Pharmaceutics, College of Pharmacy, University of Hafr Al Batin, Hafar Al Batin 39524, Saudi Arabia.ORCID 0000-0001-6543-0990
Mariappan RajanBiomaterials in Medicinal Chemistry Laboratory, Department of Natural Products Chemistry, School of Chemistry, Madurai Kamaraj University, Madurai 625021, India.
Madurai Kamaraj University · INMajmaah University · SAUniversity of Hafr Al-Batin · SAUniversity of the Witwatersrand · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibioticsmethicillin-resistant Staphylococcus aureus (MRSA)pathogenesissuperbugtreatment

Identifiers

PMID35625250
PMCPMC9137690
OpenAlexW4225116928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.